Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 700 of 1294 entries
View as:

Investigating Bioequivalence Between Single-dose Liraglutide Administered Subcutaneously With Two Different Pen-injectors

Phase: N/A Priority: Normal
NCT ID: NCT02207348 Org: User:
Start: 08/31/14 End: 09/30/14 Due: 09/30/15

An International Chart Review and Survey for the Prevalence and Clinical Management of Atherosclerotic Cardiovascular Diseases in Patients With Type 2 Diabetes Across Countries in the Middle East and Africa

Phase: N/A Priority: Normal
NCT ID: NCT05317845 Org: User:
Start: 04/21/22 End: 08/31/22 Due: 08/31/23

Non-interventional Study of Patients Using Norditropin® for Growth Hormone Deficiency or Turner Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01604161 Org: User:
Start: 05/31/05 End: 06/30/15 Due: 06/30/16

Special Survey for Type 1 or Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01487408 Org: User:
Start: 04/30/02 End: 10/31/09 Due: 10/31/10

Safety and Tolerability of Liraglutide in Healthy Japanese Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01620476 Org: User:
Start: 09/30/03 End: 03/31/04 Due: 03/31/05

A Survey to Evaluate Diabetes Management, Control, Complications and Psychosocial Aspects of Diabetic Patients in Philippines

Phase: N/A Priority: Normal
NCT ID: NCT00874159 Org: User:
Start: 04/30/09 End: 10/31/09 Due: 10/31/10

Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®

Phase: N/A Priority: Normal
NCT ID: NCT04469855 Org: User:
Start: 07/27/20 End: 07/31/25 Due: 07/31/26

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

Phase: N/A Priority: Normal
NCT ID: NCT05003440 Org: User:
Start: 08/19/21 End: 01/19/22 Due: 01/19/23

A Trial Investigating the Possible Difference in Development of Type 2 Diabetes Between Caucasian and Japanese Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00897169 Org: User:
Start: 06/30/09 End: 12/31/10 Due: 12/31/11

A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneous NNC0143-0406 A 0.6 mmol/L in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02612844 Org: User:
Start: 11/30/15 End: 06/30/16 Due: 06/30/17

Non-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT01586936 Org: User:
Start: 03/10/99 End: 03/09/10 Due: 03/09/11

Effect of Repaglinide on Postprandial Lipemia in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01605773 Org: User:
Start: 11/08/01 End: 03/13/03 Due: 03/13/04

A Research Study to Compare How Much Semaglutide is Found in the Blood With Different Tablets of Oral Semaglutide in Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05784402 Org: User:
Start: 03/16/23 End: 03/28/24 Due: 03/28/25

The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02098395 Org: User:
Start: 05/31/14 End: 04/30/15 Due: 04/30/16

Multi-national Study Investigating the Effect and Safety of rFXIII on Transfusion Needs in Patients Undergoing Heart Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00914589 Org: User:
Start: 07/31/09 End: 02/28/11 Due: 02/28/12

Clinical Outcomes of NovoSeven® Treatment in Severe Postpartum Haemorrhage - a Study at the University Hospital of Bern

Phase: N/A Priority: Normal
NCT ID: NCT04444856 Org: User:
Start: 06/29/20 End: 01/13/21 Due: 01/13/22

A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics

Phase: N/A Priority: Normal
NCT ID: NCT01636817 Org: User:
Start: 08/31/12 End: 11/30/14 Due: 11/30/15

Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.

Phase: N/A Priority: Normal
NCT ID: NCT00476437 Org: User:
Start: 04/30/07 End: 11/30/07 Due: 11/30/08

Pharmacokinetics of Insulin Detemir in Subjects With Type 1 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01542450 Org: User:
Start: 08/31/02 End: 02/28/03 Due: 02/28/04

Controlled Study to Evaluate the Efficacy and Safety of the Treatment With Growth Hormone in Tibia Fractures

Phase: N/A Priority: Normal
NCT ID: NCT00254514 Org: User:
Start: 08/31/01 End: 10/31/03 Due: 10/31/04

Obesity and Cardiovascular Diseases, Cross-sectional Study in Saudi Arabia

Phase: N/A Priority: Normal
NCT ID: NCT05642533 Org: User:
Start: 12/31/22 End: 09/14/23 Due: 09/14/24

Effect of Fiasp® in Type 1 Diabetes Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03895515 Org: User:
Start: 01/03/20 End: 12/21/20 Due: 12/21/21

Comparison of the Efficacy and Safety of Two Intensification Strategies in Subjects With Type 2 Diabetes Inadequately Controlled on Basal Insulin and Metformin

Phase: N/A Priority: Normal
NCT ID: NCT01388361 Org: User:
Start: 09/30/11 End: 07/31/12 Due: 07/31/13

Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01579968 Org: User:
Start: 03/10/99 End: 03/09/10 Due: 03/09/11

A Research Study to Compare Two Types of Insulin: Insulin 287 and Insulin Glargine in People With Type 2 Diabetes Who Have Not Used Insulin Before

Phase: N/A Priority: Normal
NCT ID: NCT03951805 Org: User:
Start: 05/09/19 End: 01/17/20 Due: 01/17/21